264 related articles for article (PubMed ID: 16728394)
1. Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition.
Dao KK; Teigen K; Kopperud R; Hodneland E; Schwede F; Christensen AE; Martinez A; Døskeland SO
J Biol Chem; 2006 Jul; 281(30):21500-21511. PubMed ID: 16728394
[TBL] [Abstract][Full Text] [Related]
2. Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation.
Wang Z; Dillon TJ; Pokala V; Mishra S; Labudda K; Hunter B; Stork PJ
Mol Cell Biol; 2006 Mar; 26(6):2130-45. PubMed ID: 16507992
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the carboxyl-terminal regional of the cAMP-dependent protein kinase type I alpha regulatory subunit to cyclic nucleotide interactions.
Kapphahn MA; Shabb JB
Arch Biochem Biophys; 1997 Dec; 348(2):347-56. PubMed ID: 9434747
[TBL] [Abstract][Full Text] [Related]
4. Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting.
Yu S; Mei FC; Lee JC; Cheng X
Biochemistry; 2004 Feb; 43(7):1908-20. PubMed ID: 14967031
[TBL] [Abstract][Full Text] [Related]
5. Origin and Isoform Specific Functions of Exchange Proteins Directly Activated by cAMP: A Phylogenetic Analysis.
Ni Z; Cheng X
Cells; 2021 Oct; 10(10):. PubMed ID: 34685730
[TBL] [Abstract][Full Text] [Related]
6. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension.
Christensen AE; Selheim F; de Rooij J; Dremier S; Schwede F; Dao KK; Martinez A; Maenhaut C; Bos JL; Genieser HG; Døskeland SO
J Biol Chem; 2003 Sep; 278(37):35394-402. PubMed ID: 12819211
[TBL] [Abstract][Full Text] [Related]
7. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS).
Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL
J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976
[TBL] [Abstract][Full Text] [Related]
8. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.
Kim C; Cheng CY; Saldanha SA; Taylor SS
Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648
[TBL] [Abstract][Full Text] [Related]
9. Isoform specific differences in binding of a dual-specificity A-kinase anchoring protein to type I and type II regulatory subunits of PKA.
Burns LL; Canaves JM; Pennypacker JK; Blumenthal DK; Taylor SS
Biochemistry; 2003 May; 42(19):5754-63. PubMed ID: 12741833
[TBL] [Abstract][Full Text] [Related]
10. Conformational analysis of Epac activation using amide hydrogen/deuterium exchange mass spectrometry.
Brock M; Fan F; Mei FC; Li S; Gessner C; Woods VL; Cheng X
J Biol Chem; 2007 Nov; 282(44):32256-63. PubMed ID: 17785454
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinases, but not exchange proteins directly activated by cAMP (Epac), mediate thyrotropin/cAMP-dependent regulation of thyroid cells.
Dremier S; Milenkovic M; Blancquaert S; Dumont JE; Døskeland SO; Maenhaut C; Roger PP
Endocrinology; 2007 Oct; 148(10):4612-22. PubMed ID: 17584967
[TBL] [Abstract][Full Text] [Related]
12. Understanding cAMP-dependent allostery by NMR spectroscopy: comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states.
Mazhab-Jafari MT; Das R; Fotheringham SA; SilDas S; Chowdhury S; Melacini G
J Am Chem Soc; 2007 Nov; 129(46):14482-92. PubMed ID: 17973384
[TBL] [Abstract][Full Text] [Related]
13. EPAC activation inhibits acetaldehyde-induced activation and proliferation of hepatic stellate cell via Rap1.
Yang Y; Yang F; Wu X; Lv X; Li J
Can J Physiol Pharmacol; 2016 May; 94(5):498-507. PubMed ID: 26854595
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs.
de Rooij J; Rehmann H; van Triest M; Cool RH; Wittinghofer A; Bos JL
J Biol Chem; 2000 Jul; 275(27):20829-36. PubMed ID: 10777494
[TBL] [Abstract][Full Text] [Related]
15. Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes.
Pereira L; Rehmann H; Lao DH; Erickson JR; Bossuyt J; Chen J; Bers DM
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3991-6. PubMed ID: 25829540
[TBL] [Abstract][Full Text] [Related]
16. Dynamically driven ligand selectivity in cyclic nucleotide binding domains.
Das R; Chowdhury S; Mazhab-Jafari MT; Sildas S; Selvaratnam R; Melacini G
J Biol Chem; 2009 Aug; 284(35):23682-96. PubMed ID: 19403523
[TBL] [Abstract][Full Text] [Related]
17. Structure and regulation of the cAMP-binding domains of Epac2.
Rehmann H; Prakash B; Wolf E; Rueppel A; de Rooij J; Bos JL; Wittinghofer A
Nat Struct Biol; 2003 Jan; 10(1):26-32. PubMed ID: 12469113
[TBL] [Abstract][Full Text] [Related]
18. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase.
Herberg FW; Taylor SS; Dostmann WR
Biochemistry; 1996 Mar; 35(9):2934-42. PubMed ID: 8608131
[TBL] [Abstract][Full Text] [Related]
19. The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1).
Courilleau D; Bouyssou P; Fischmeister R; Lezoualc'h F; Blondeau JP
Biochem Biophys Res Commun; 2013 Oct; 440(3):443-8. PubMed ID: 24099776
[TBL] [Abstract][Full Text] [Related]
20. cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP.
Zawadzki KM; Taylor SS
J Biol Chem; 2004 Feb; 279(8):7029-36. PubMed ID: 14625280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
